Stock·NASDAQ·Healthcare
Legend Biotech Corporation (LEGN)
- Market cap
- $3.59B
- Dividend yield
- 0.00%
- Street target
- $48.00median of 13 analysts
- 52-week range
- $16.24 $37.50
The short version
Where LEGN stands today, in four lines, and what CleaRank Financial AI makes of it.
LEGN at a glance
Legend Biotech Corporation (LEGN): Hold, 42/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($19.71 and $22.24).
- Earnings LEGN beat estimates in 3 of its last 8 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $947K and made no open-market purchases over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Legend Biotech Corporation (LEGN) Hold, with a model score of 42/100.
The analysts' outlook lifts the score the most: 8 of 13 analysts rate the stock a buy, and the median target is 159.7% above the price. The trend pulls the score down the most. The price is 16.89% below its 200-day average and 6.26% below its 50-day average, and the 50-day average is 11.34% below the 200-day. The 50-day stands at $19.71 and the 200-day at $22.24. Over the past year the price fell 42.89%.
Only on CleaRank
Figures we compute ourselves from LEGN's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $18.48 is 6.3% below the 50-day simple moving average of $19.71.Price above its 200-day average ›
The price is 16.9% below the 200-day simple moving average of $22.24.50-day average above the 200-day ›
The 50-day average ($19.71) is 11.3% below the 200-day average ($22.24), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 11% of its 52-week range, between $16.24 and $37.50.
LEGN share price
Pick a period: each tab shows how far LEGN has moved over it, to the last close.
Today's trading
Where LEGN sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S below the sector median ›
The price-to-sales ratio of 3.03 is 10.9% below the sector median of 3.4.Profitable over the last 12 months ›
Net income over the last 12 months was $-91.5M on revenue of $1.3B, a net margin of -7.2%.Beat estimates in most recent reports ›
LEGN beat the EPS estimate in 3 of its last 8 reports.
Key statistics
The headline figures for LEGN.
As of October 17, 2026, LEGN trades at $18.48, with a market value of $3.59B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of LEGN's valuation, growth and risks.
Legend Biotech Corporation (LEGN) has no readable P/E, since the company lost money over the last 12 months, so that its P/E is not meaningful. Against sales, LEGN trades at 3.03 times, which is 10.9% below the sector median of 3.4. Its market capitalisation is $3.6B, and its trailing earnings come to -$0.58 a share.
LEGN is losing money: its net margin is -7.20% and its operating margin is 14.89%. Revenue growth of 51.90% runs 43.8 percentage points faster than the sector median of 8.1%. Return on equity is -8.08%, below the sector median of 7.3%. Debt-to-equity of 0.23 completes the balance sheet picture.
LEGN reported $0.32 a share, topping a $0.28 estimate in the August 11, 2026 report and beating it by 14.29%. Even so, the stock dropped 5.41% in the next session.
LEGN beat estimates in 3 of the last 8 reports, yet the stock still fell in the first session after 1 of those 3 beats. Analysts expect EPS of -$0.01 for this fiscal year and $0.6831 for next year.
LEGN's daily returns have a 30-day standard deviation of 3.37%. The trend leans against holders until the price climbs back above its moving averages. At 50.72% below its 52-week high of $37.50, the stock has far to recover. Insiders sold $947K over the last 18 months and bought nothing on the open market. Insider sales are often planned in advance, so they carry less weight than purchases would.
LEGN against the Healthcare sector
How LEGN compares with the median Healthcare stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, LEGN trades at 3.03x, -11% versus the sector average of 3.40x.
Return vs XLV: Since May 6, 2025, LEGN has lost 41.1% against a gain of 31.6% for XLV.
Performance against XLV
LEGN and the Healthcare sector fund over the same days.
Revenue and earnings
How much LEGN sells, and how much of it becomes profit.
Revenue growth: Revenue grew 64.0% in FY2025 to $1.0B, from $627M a year earlier.
Profit margin: The net margin was -28.8% in FY2025, down from -28.2% the year before.
Loss-making: LEGN lost $297M in FY2025.
Earnings reality check
Did LEGN beat what analysts expected, and how did the stock react?
Earnings record: LEGN beat the analyst estimate in 3 of the last 8 quarters.
Market reaction: The stock fell in the first session after 1 of those 3 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 11, 2026after close | $0.28 | $0.32 | +14.29% | -5.41% | +0.41% |
| May 4, 2026after close | $0.78 | $0.87 | +11.54% | +7.58% | -3.47% |
| Mar 10, 2026after close | $0.19 | -$0.16 | -184.21% | +3.63% | -5.16% |
| Nov 12, 2025after close | -$0.18 | -$0.22 | -22.22% | -0.53% | -10.18% |
| Aug 11, 2025after close | -$0.23 | -$0.68 | -195.65% | +2.07% | +3.34% |
| May 13, 2025after close | -$0.34 | -$0.54 | -58.82% | -10.55% | -3.25% |
| Mar 11, 2025after close | -$0.43 | $0.14 | +132.56% | +2.82% | +1.86% |
| Nov 12, 2024after close | -$0.60 | -$0.68 | -13.33% | -2.07% | -4.43% |
As of October 17, 2026, LEGN has beaten the analyst EPS estimate in 3 of its last 8 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 11, 2026, came in 14.29% above the estimate and the stock moved -5.41% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 46.2, in neutral territory.RSI above 50 ›
An RSI of 46.2 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of LEGN
The score, the reasoning behind it, and what could move the price next.
LEGN is in a downtrend: the price of $18.48 sits 16.89% below its 200-day average of $22.24 and 6.26% below its 50-day average of $19.71. Near the bottom of its 52-week range, the price is 13.79% above the low of $16.24 and 50.72% below the high of $37.50. Because the 50-day average is 11.34% below the 200-day, the moving averages back up the weakness rather than pointing against it.
Recent gains sit against a weaker longer record: the price rose 8.71% over the past month, fell 16.98% over the past three months and fell 42.89% over the past year. Volume in the last session ran 38.6% above its average, on a day the price fell 6.67%. The 14-day RSI of 46.2 is in the neutral zone, and the MACD line is negative.
Earnings beat ›
The August 11, 2026 report beat the EPS estimate by 14.29%, and the share price fell 5.41% in the first session after it.
Source: Earnings report, August 11, 2026
Rating reaffirmed ›
JP Morgan kept its Neutral rating on October 9, 2026.
Source: Analyst action, JP Morgan, October 9, 2026
- The two closest levels matter most: the 20-day EMA at $18.87 sits above the price, and the 52-week low at $16.24 sits below it.
- The 14-day RSI reads 46.2, which is neutral, and the MACD line is negative. Readings above 70 or below 30 point to stretched momentum.
- The share price fell 5.41% in the first session after the August 11, 2026 report. LEGN has beaten estimates in 3 of the last 8 reports.
The trend is down because LEGN trades under both its 50-day ($19.71) and 200-day ($22.24) averages. Reclaiming the 50-day would be the first sign of repair. The first level above the price is the 20-day EMA at $18.87.
The next level below the price is the 52-week low at $16.24. The 14-day RSI of 46.2 sits in neutral territory, inside the 40 to 60 band.
Technical indicators
Momentum and trend for LEGN, from its daily closes.
As of October 17, 2026, with LEGN at $18.48, its 14-day RSI is 46.2 (neutral territory), its 50-day simple moving average is $19.71 and its 200-day is $22.24.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What LEGN moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, LEGN's 1-year correlation of daily returns is +0.14 with S&P 500 (SPY), +0.14 with Nasdaq 100 (QQQ), -0.03 with Bitcoin (BTC) and +0.08 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
8 of 13 analysts rate it a buy or strong buy, 5 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $48.00 is 159.7% above the price.More buy ratings than three months ago ›
8 of 13 rate it a buy now, against 11 of 15 three months ago.
LEGN Wall Street View
12-month price targets
The price, $18.48, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | JP Morgan | Maintains | Neutral |
| Oct 8, 2026 | RBC Capital | Maintains | Outperform |
| Sep 30, 2026 | HC Wainwright & Co. | Reiterates | Buy |
| Sep 11, 2026 | Barclays | Maintains | Overweight |
| Sep 4, 2026 | HC Wainwright & Co. | Reiterates | Buy |
| Aug 12, 2026 | Morgan Stanley | Maintains | Overweight |
As of October 17, 2026, 13 Wall Street analysts cover LEGN: 8 rate it a buy or strong buy, 5 a hold and 0 a sell or strong sell. Their 12-month price targets range from $24.00 to $74.00, with a median of $48.00, 159.7% above the price of $18.48.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
LEGN trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
LEGN moves about 3.4% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much LEGN tends to move, against the market and on its own.
The long record
LEGN's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 3.37% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 78.1%, from July 2023 to February 2026; the price is still 75.7% below that peak.Most 1-year holds ended higher ›
50% of 1-year holding periods in the last 6 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in June 2020 is now worth $4,994.59, against $26,124 in the S&P 500 (SPY).
LEGN Drawdowns & Recovery
As of October 17, 2026, LEGN's worst peak-to-trough fall over the last 6 years with dividends reinvested was -78.1% (July 2023 to February 2026); it is still 75.7% below that peak, and 50% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into LEGN in June 2020 is worth now, against the same amount in the S&P 500.
Against the market: LEGN trailed the S&P 500 over this period: $4,994.59 against $26,124.
A $10,000 investment in LEGN in June 2020 would be worth about $4,995 today with dividends reinvested, compared with about $26,124 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to LEGN, and which have not.
Strongest month, June: an average of +11.92%, up in 5 of 6 years.
Weakest month, December: an average of -8.57%, up in 2 of 6 years.
This month, October: has averaged +0.87%, up in 2 of 6 years. Past seasonality does not repeat on schedule.
Over the last 7 years, LEGN's strongest calendar month has been June (average +11.92%, up in 5 of 6 years) and its weakest December (average -8.57%, up in 2 of 6 years).
Average return for each calendar month over the last 7 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in LEGN, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in LEGN today could grow to about $7,410 by 2036 in the base case, with a 90th-percentile outcome near $56,219 and a 10th-percentile outcome around $977. Projections are statistical simulations, not guarantees.
LEGN Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $16.39 for LEGN by 2030 in the base case, from $18.48 today (0.9x over 4 years). The 10th-percentile path ends near $4.55. These are outcomes of a Monte Carlo simulation run on LEGN's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $9.45 | $17.93 | $34.04 | |
| 2028 | $7.03 | $17.40 | $43.08 | |
| 2029 | $5.57 | $16.89 | $51.25 | |
| 2030 | $4.55 | $16.39 | $59.05 | |
| 2031 | $3.80 | $15.91 | $66.67 |
Method: a lognormal simulation of LEGN's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
LEGN insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought LEGN shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, LEGN insiders reported 4 open-market sales worth $947K and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 29, 2026 | Corazon Corsee D Sanders
Director
|
Sell | 27.4K | $515.1K |
| Sep 24, 2026 | Patrick John Ph.d. Casey
Director
|
Grant | 21.0K | - |
| Sep 24, 2026 | Tomas J. Heyman
Director
|
Grant | 21.0K | - |
| Sep 24, 2026 | Darren Xiaohui Ji
Director
|
Grant | 28.3K | - |
| Sep 24, 2026 | Li Mao
Director
|
Grant | 21.0K | - |
| Sep 24, 2026 | Peter Ph.d. Salovey
Director
|
Grant | 28.3K | - |
| Sep 24, 2026 | Corazon Corsee D Sanders
Director
|
Grant | 21.0K | - |
| Sep 21, 2026 | Carlos E Santos
Chief Financial Officer
|
Sell | 5.4K | $100.6K |
| Sep 21, 2026 | Carlos E Santos
Chief Financial Officer
|
Grant | 19.7K | - |
| Aug 14, 2026 | Alan Bash
Chief Executive Officer
|
Grant | 4.9K | - |
| Jun 30, 2026 | Patrick John Ph.d. Casey
Director
|
Sell | 6.0K | $173.3K |
| Jun 30, 2026 | Ying Huang
Chief Executive Officer
|
Grant | 3.4K | - |
| Jun 25, 2026 | Ying Huang
Chief Executive Officer
|
Sell | 5.6K | $158.2K |
Source: TwelveData, from reported insider filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.